financetom
Business
financetom
/
Business
/
Elara Capital sees 25-30% upside on Sun TV as well as Zee from current levels
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Elara Capital sees 25-30% upside on Sun TV as well as Zee from current levels
Aug 28, 2023 5:33 AM

Sun TV Network, a prominent player in the Indian media industry, has been making headlines recently with its impressive growth and potential upside. Similarly, the proposed merger between Zee Entertainment Enterprises and Sony Pictures Networks India is also being discussed as one of the significant developments in the country's media industry.

Share Market Live

NSE

Karan Taurani, Senior VP-Research Media Analyst at Elara Capital, shared valuable insights on Sun TV's performance and the anticipated Zee-Sony merger.

During an interview with CNBC-TV18, Taurani said that Sun TV, excluding its Indian Premier League (IPL) ventures, is poised for a significant upswing, adding that there is still a 25-30 percent upside potential from its current levels.

“There is still a potential of at least 25 percent upside on SUN TV primarily because of rerating of the core broadcasting business,” he said.

Sun TV Network has chosen not to expand its digital network. While many media companies are exploring the digital space, Sun TV's strategic focus remains primarily on its television offerings.

Sun TV Network, headquartered in Chennai, Tamil Nadu, is a significant part of the Sun Group and stands as one of Asia's largest TV networks. Founded by Kalanithi Maran on April 14, 1992, the company has achieved remarkable success. Sun TV Network primarily operates in four South Indian states: Tamil Nadu, Karnataka, Andhra Pradesh, and Kerala. Among its impressive array of channels, Sun TV, the flagship channel, dominates the Tamil General Entertainment Channel (GEC) genre with a market share exceeding 40 percent. This formidable presence underscores Sun TV Network's influence and reach across South India.

Switching gears to the broader media landscape, Taurani also commented on the Zee-Sony merger. He expressed optimism about the merger's progress, stating that it seems likely to proceed, with or without the involvement of Punit Goenka.

Punit Goenka, the former chief of Zee Entertainment Enterprises Ltd, on Friday, moved the Securities Appellate Tribunal (SAT) seeking a stay on the Securities and Exchange Board of India's (SEBI) order barring him from holding key positions within four Zee group firms and in the merged entity of Zee Entertainment Enterprises Ltd (ZEEL) and Sony Pictures Networks India. The SEBI order has alleged that Goenka and his father Subhash Chandra, former chairman of ZEEL, abused their roles as directors and Key Managerial Personnel (KMPs) of a listed company by siphoning off funds for their own benefit. Goenka is likely to question how can he be kept out of office until the probe is completed, which SEBI said could take eight months.

“We don’t foresee Sony waiting for eight months for the merger to happen. We believe that there is a higher likelihood for the merger to go through without Punit Goenka. The merger is well on track with or without him,” Taurani said.

Taurani estimated that the entire merger process will take approximately two months to complete. Furthermore, Taurani believes that the merged entity will be listed this fiscal year, adding another layer of intrigue to the deal.

For investors in Zee Entertainment, Taurani's insights provide reason for optimism. He suggested that there is a likelihood of Zee Entertainment's stock price crossing Rs 340 mark post-merger, which would be a substantial increase from its current levels.

“Once the roadblocks are cleared over the next two months, there is high likelihood of the stock reaching Rs 340-350 levels. So there is a good amount of 25-30 percent potential upside from current levels,” he said.

For more details, watch the accompanying video

(Edited by : C H Unnikrishnan)

First Published:Aug 28, 2023 2:33 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia supplier SK Hynix says begins mass production of 12-layer HBM3E chips
Nvidia supplier SK Hynix says begins mass production of 12-layer HBM3E chips
Sep 26, 2024
SEOUL, Sept 26 (Reuters) - The world's second-largest memory chipmaker SK Hynix ( HXSCF ) said on Thursday it began mass production of a 12-layer version of the latest generation of high-bandwidth memory (HBM) chips, to meet demand from the current AI boom. The Nvidia ( NVDA ) supplier said in a statement it was the world's first latest-generation HBM...
Caterer Sodexo weighs acquisition of US rival Aramark, Bloomberg News reports
Caterer Sodexo weighs acquisition of US rival Aramark, Bloomberg News reports
Sep 26, 2024
(Reuters) - French food catering firm Sodexo is exploring a potential acquisition of its U.S. rival Aramark ( ARMK ), Bloomberg News reported on Wednesday. Sodexo has been periodically discussing the deal with food and facilities management provider Aramark ( ARMK ) in recent months, the report said, citing people familiar with the matter. However, there is no guarantee that...
Northrop Grumman selected to continue development of glide phase missile defense systems
Northrop Grumman selected to continue development of glide phase missile defense systems
Sep 26, 2024
Sept 25 (Reuters) - Northrop Grumman ( NOC ) said on Wednesday the U.S. Missile Defense Agency (MDA) has selected the defense company to continue developing glide phase interceptor systems capable of countering hypersonic missiles. The MDA said in a statement it is leading the development of the systems for the Pentagon alongside Japan's Ministry of Defense, adding that follow-on...
Pfizer withdraws sickle cell disease treatment on risk of complication, death
Pfizer withdraws sickle cell disease treatment on risk of complication, death
Sep 26, 2024
Sept 25 (Reuters) - U.S. drugmaker Pfizer ( PFE ) said on Wednesday it is withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks of a painful complication and deaths. Pfizer ( PFE ) bought Oxbryta, also known as voxelotor, as part of its $5.4 billion buyout of Global Blood Therapeutics in 2022....
Copyright 2023-2026 - www.financetom.com All Rights Reserved